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There is growing demand for robust DNA assembly strategies to quickly and accurately fabricate genetic circuits for
synthetic biology. One application of this technology is reconstitution of multi-gene assemblies. Here, we integrate
a new software tool chain with 2ab assembly and show that it is robust enough to generate 528 distinct composite
parts with an error-free success rate of 96%. Finally, we discuss our findings in the context of its implications for
biosafety and biosecurity.
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Synthetic biology uses a ground-up approach to genetic
engineering with a vision to solve the technical and
conceptual bottlenecks associated with the field. Standard
biological parts have emerged as a mechanism through
which researchers can emphasize the engineering compo-
nent of genetic engineering. To viably implement such a
vision, however, a new experimental approach that can
systematically identify and optimize biological function is
needed. Currently there are no established methodologies
to encapsulate biological part function such that meaning-
ful, quantitative predictions about genetic composition can
be made a priori. Although in practice post-hoc analyses of
projects provide insights into the individual properties of
parts, most engineering strategies require either an ad-hoc
search of intuitively-chosen constructs or library-based
approaches. In the hands of experienced researchers these
methods can be quite effective for systems containing up
to 6 genes [1]. Nevertheless, beyond this scale these meth-
ods appear to be insufficient. We have implemented an
alternate approach to experimental design that uncovers
optimal solutions to design problems by linking automated
DNA fabrication to effective construct screening. In the* Correspondence: jcanderson@berkeley.edu
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reproduction in any medium, provided the orfirst step, we use cost effective, fast and scalable DNA
fabrication methods to generate large sets of explicit DNA
constructs automatically. In the second step, we function-
ally screen those DNAs via readily available assays that are
also automatable, cost effective, fast and scalable. Addition-
ally, we integrate these activities under a software tool
chain specifically developed for these types of applications.
By linking these functions together into a single process we
not only uncover optimal solutions to a design problem,
but also encapsulate important data about the parts from
which they were composed. In turn, this leads to greater
insight and faster optimization.
To illustrate how this alternate approach can be imple-
mented in a synthetic biology lab we have focused on
the production of multi-subunit protein complexes. The
ability to produce functional protein from recombinant
sources is essential in synthetic biology and for the
scientific community at large. Nevertheless, producing
these proteins quickly and successfully, particularly in
the case of multi-subunit complexes, can be challenging.
Given an overall lack of tools available to quickly and
effectively identify appropriate conditions a priori,
production efforts are often inefficient, resulting in poor
or failed attempts. In these cases, original constructs
need to be modified, which is often costly, labor-
intensive and time-consuming, particularly if multiple
rounds of modification are necessary. An attractive alter-
native to sequential, slow, expensive, multiple rounds ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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permutations of a particular genetic architecture, followed
by rapid functional screening of those permutations.
Currently however, the assembly of long, error-free DNAs
of the type required to build complex, tunable genetic
circuits is the primary bottleneck in the field.
In recent years several DNA assembly strategies have
been described, including Gibson, SLIC, Golden Gate,
and various BioBrick approaches (for reviews see [2-5]).
Each method has a range of advantages and disadvantages,
and thus, different construction scenarios are best served
by different technologies. Some of these methods can be
used to assemble DNAs simultaneously. However, in the
context of the design paradigm described here, a key par-
ameter to consider is whether a particular strategy can be
implemented in an automated platform that is amenable to
scaling. Clearly, some chemistries will automate better than
others. Thus, indentifying DNA fabrication protocols that
are compatible with automation and scaling is an essential
step towards easing the construction jam. Furthermore,
quick functional screens of assembled permutations, via
established assays that can also be automated and scaled, is
essential for the isolation and control of most, if not all, of
the variables affecting a particular project.
Here, we describe the construction of a set of 528
distinct composite devices that sample a large combina-
torial space. Specifically, every device is a bi-cistronic
operon constructed out of 8 standard basic parts.
Operons encode two separate protein fusions containing
an epitope tag either at the N- or C- terminus that is
used to establish function. With support from software
tools specifically developed for these types of DNA
fabrication experiments [6,7], we have generated all
constructs automatically, using a methodology called
2ab assembly. 2ab assembly is a single iterative process,
based on the BglBricks standard [8], that is amenable to
high-throughput automation and scaling [7]. Like other
BioBricks™-based schemes, the BglBricks standard is
based on unique restriction enzyme sites that flank the
part (BglII at the 50 end and BamHI at the 30 end) and
generate compatible cohesive ends that can be joined
back together. When two parts are joined using simple
restriction digestion and ligation reactions, the resulting
composite part also contains unique BglII and BamHI
sites flanking the 50 and 30 ends, respectively, as well as a
small scar sequence encoding Gly-Ser separating input
parts. As we show here however, 2ab assembly is not
solely dependent on the BglBricks standard. In fact, 2ab
assembly is flexible enough to accommodate alternate
assembly standards as well. Using simple ELISA assays
we have probed a variety of parameters that influence
protein expression in functional form. Further, we
surveyed and identified optimal architectures that result
in the expression of functional protein complexes. Weshow that 2ab assembly is robust enough to generate
hundreds of large error-free DNAs of the type required
in a single experiment within the paradigm of synthetic
biology with a 96% success rate.
Results
Selection and design of an appropriate DNA assembly
set: bi-cistronic operons of Mediator complex for protein
production
To test this new experimental approach we set out to
generate a large set of DNA constructs that would allow us
to measure the robustness of our assembly methodology.
Further, we wanted to make use of assembled DNAs to
address a challenging biological problem of significant
current relevance. The expression and purification of
multi-subunit protein complexes in soluble form is one
such challenge, particularly because there are no tools that
can be used at the outset of an experiment to select strat-
egies that will yield successful results. Protein production is
influenced by multiple variables, including expression host,
construct composition and architecture, timing, rate, and
temperature of expression, purification method, and so on.
In the case of multi-subunit complexes, potential challenges
can be exacerbated because individual subunits may require
co-expression and/or independent regulation of expression.
Thus, it may be necessary to consider separate control of
additional variables, such as expression timing, rate and
stoichiometry, which can further complicate a project.
As proof-of-concept for our 2ab assembly methodology
we put together a set of 528 unique plasmids encoding
permutations of bi-cistronic operons that could be used to
express, identify and purify distinct epitope-tagged
proteins known to form a stable complex in E. coli. The
proteins selected were Med7 and Med21, two subunits of
the S. cerevisiae Mediator complex. Mediator is a large
protein machine (more than 1 MDa in size, containing 20+
independent subunits) that functions as a key regulator of
eukaryotic transcription [9,10]. Despite its importance,
however, the size and complexity of Mediator pose specific
research challenges. Thus, tools that can help address such
difficulties are useful to begin to address existing obstacles.
Med7 and Med21 were specifically selected as a suitable
pair for this assembly because they have been previously
purified in E. coli and because E. coli-expressed Med7 and
Med21 can form stable hetero-dimers [11]. Thus, such an
assembly set would allow us to test the functionality of our
constructs post-assembly in a variety of ways: for example,
by measuring relative protein expression profiles of
individual subunits; or by measuring the degree of protein-
protein interaction between separate subunits.
We tagged each Mediator subunit with a small epitope
that would enable a variety of downstream assays,
including but not limited to, detection of individual subunit
expression levels and protein-protein interactions. We used
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Myc, S, Strep, T7, V5 and VSV) (full details provided in
Additional file 1) for which there are commercially-
available antibodies (listed in Additional file 2). We varied
the location of the tag relative to the protein ORF (either at
the N- or the C-terminus) and we sampled all possible
architectures: both subunits tagged at the N-terminus [NN]
or C-terminus [CC]; first subunit tagged at the N-terminus
and second subunit tagged at the C-terminus [NC]; and
vice-versa [CN] (Figure 1). In each case, tags were separated
from their corresponding ORFs by a TEV protease cleavage
in order to facilitate tag removal if desired. Expression of
every operon was placed under the control of an
arabinose-inducible Pbad promoter and terminator.
All bi-cistronic operons were composed of 8 basic
parts each: a promoter to drive expression, followed by
the first ORF (consisting of 3 basic parts: Med7 and
one epitope tag, separated by a TEV cleavage site),Figure 1 Assembly of bi-cistronic operons. (A) Basic parts used in the a
sets. N-terminal sets contain RBSs as a component of the part, while C-term
combinatorial architectures for a set of constructs containing two ORFs (Me
the N- or C-terminus with different tags (VSV-tag for Med7 and E-tag for M
arrangement, 4 different construct architectures are possible: in the NN con
configuration the first ORFs is tagged at the N-terminus and the second OR
tagged at the C-terminus and the second ORF is tagged at the N-terminusfollowed by the second ORF (also consisting of 3 basic
parts: Med21 and one epitope tag, separated by a TEV site),
followed by a terminator. The Eugene programming lan-
guage, which was specifically created for the specification of
synthetic biological designs from a collection of individual
standard parts [6], was used to generate our assembly set
given a defined set of composition constraints. These con-
straints are declarative rules that either prevent or ensure
the appearance of specific tag combinations in a construct.
The general bi-cistronic operon architecture can then be
permuted while adhering to these constraints. Given 12
tags and 4 possible tagging architectures (NN, NC, CN and
CC), the number of bi-cistronic operons needed to sample
the entire combinatorial space was 528.
All 528 unique bi-cistronic operons were assembled
from a total of 31 basic parts (Additional file 1). Basic
parts encoding tags and ORFs were gene synthesized in
two versions in order to simplify construction: eitherssembly. ORFs and tags were synthesized as either N- or C-terminal
inal sets contain stop codons at the end of the part. (B) Sample
d7 in the first position and Med21 in the second position) tagged at
ed21). Every operon is composed of 8 basic parts. For this
figuration both ORFs are tagged at the N-terminus; in the NC
F is tagged at the C-terminus; in the CN configuration the first ORFs is
; in the CC configuration both ORFs are tagged at the C-terminus.
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stop codons at the end. Tags in the first group, referred to
as N-terminal tags, were designed to sit at the N-terminus
of Mediator subunits. They included an RBS (determined
using the RBS calculator algorithm [12] set at a target
translation rate of 10,000), an ATG start codon for initi-
ation of translation, and lacked an in-frame stop codon at
the end. Tags in second group, referred to as C-terminal
tags, were designed to sit at the C-terminus of Mediator
subunits. They did not include an RBS or a start codon, but
they did contain an in-frame stop codon at the end. Medi-
ator subunits were similarly synthesized. N-terminal ORFs
accepted N-terminal tags and did not include an RBS, but
did contain an in-frame stop codon. C-terminal ORFs
accepted C-terminal tags and included an RBS (determined
as above), but lacked a stop codon at the end. Both Med7
and Med21 basic parts were made as truncations that
express well in E. coli and retain their ability to interact with
each other [11]. Med7 was truncated N- and C-terminally
and included amino acids 102–205, while Med21 was trun-
cated C-terminally only and included amino acids 1–132.
The protease cleavage site part was gene synthesized
without start or stop codons because it would separate tags
from their corresponding Mediator subunits.
Assembly of all target plasmids was completed in 3
stages of 2ab assembly, according to an assembly tree
generated by the AssemblyManager software tool, using
a robotics platform containing a Biomek 3000 liquid
handling robot [7,13]. AssemblyManager examined the
set of devices to be constructed as a group and created an
optimal assembly tree. Optimality was defined by a minimal
depth tree, where the stages indicated sets of parallel 2ab
assembly reactions. The number of steps (a single 2ab as-
sembly reaction) in the tree was also minimized. Steps were
further reduced by sharing intermediate reactions. The tree
was then post-processed to assign antibiotic resistance
markers to input nodes. In the event of a conflicting anti-
biotic assignment, the tree was modified to accommodate
the correct resistance at the expense of the overall assembly
cost. A set of heuristics were used to accomplish this
process [13]. Specifically for this assembly, we used 31 basic
parts to make 56 composite parts (made of 2 basic parts
each) in stage 1. In stage 2, we used the parts made in stage
1 to assemble 48 composite parts (made of 4 basic parts
each). In the final stage, we used the parts made in stage 2
to assemble 528 composite parts (made of 8 basic parts
each). The target set of 528 plasmids contained a total of
3696 junctions between parts. However, most of these
junctions were not unique, and therefore in practice, only
632 total junctions were needed to complete the set.
Definition of 2ab assembly
2ab assembly is a DNA fabrication methodology that
uses 2ab reactions to build progressively more complexcomposite parts starting from basic standard biological
parts. 2ab reactions proceed in iterative cycles of restriction
digestion, ligation, transformation and selection of desired
products. The reaction enables ligation by double antibiotic
selection of 50 and 30 parts, designated as “lefty” and “righty”
respectively, located on two different assembly vectors.
The core of 2ab assembly is a set of highly engineered
plasmids containing two different antibiotic resistance
genes (from a total of three: A = ampicillin, C = chloram-
phenicol, K = kanamycin) separated by restriction site.
Given these three antibiotics, six different combinations of
assembly vectors are possible: AC, CK, KA, AK, KC and
CA. For a given vector pair to work properly during 2ab
assembly, the choice of vector pair is pre-determined
such that, once two plasmids recombine to form new
architectures, desired child products can be selected away
from undesired products, as well as from parents, using
differential antibiotic selection.
Every assembly reaction is subject to the following
three constraints: First, the antibiotic resistance markers
on every assembly vector must be distinct from one
another (vectors with two AA, CC, or KK genes are not
permitted). Second, the resistance marker on the right
position of the assembly parent donating the “lefty” part
must be the same as the resistance marker on left
position of the assembly parent donating the “righty”
part. As illustrated in Figure 2, an AK-KC vector pair
can be used to assemble parts 1 and 2 together, in that
order, provided that part 1, the “lefty” or 50 part, is on
AK, while part 2, the “righty” or 30 part, is on KC.
Similarly, a CK-KA pair can be used to assemble parts 1
and 2 together, in that order, provided that part 1 is on
CK and part 2 is on KA, and so on. The final constraint
is that the antibiotic combination associated with the
correctly assembled child must be distinguishable from
the antibiotic combination associated with the child
byproduct, as well as both of the parents. As illustrated
in Figure 2, the AK-KC vector pair produces AC and KK
combinations when recombined. Both of these are dis-
tinguishable from each other and from the parents. Al-
though in theory 2ab assembly can be carried out using
a variety of assembly standards, we have developed this
methodology for use with the previously described
BglBricks standard [8]. Thus, most of the parts in assem-
bly pairs described here are BglBricks parts flanked by
BglII and BamHI restriction sites on their 50 and 30 ends,
respectively. Further, the two antibiotic markers in every
assembly vector are separated by an XhoI site. Modifica-
tions to this set-up, where alternate assembly standards
like the BBF RFC10 have been used to compare the ro-
bustness of BglBricks-based 2ab assembly, are specifically
noted throughout.
Prior to the first round of assembly, “lefty” and “righty”
parts are defined by specific methylation. For this, lefty
Figure 2 The 2ab reaction. These are carried out in-vitro and used to make junctions between parts located on different assembly vectors. The
choice of vector pair for each junction is determined by an assembly tree generated by AssemblyManager. AssemblyManager takes into account
antibiotic resistance markers on both lefty and righty input plasmids and generates a binary tree containing legal lefty and righty pairs. In
practice, lefty and righty elements are made by harvesting plasmids from E. coli strains that specifically methylate either BglII (part J72015) or
BamHI (part J72015) restriction sites (methylated sites are shown in red and grayed over to indicate protection from digestion) [7,8]. Isolated
plasmids are then combined in one pot and digested with an enzyme cocktail containing BglII, BamHI and XhoI. Given the methylation state of
each plasmid, lefties are cut with BamHI and XhoI, while righties are cut with BglII and XhoI. Following digestion, a ligation reaction recombines
all fragments to generate a new composite part with a distinct permutation of antibiotic markers. The desired child product can then be selected
away from undesired products, including parent plasmids, by growing it in the appropriate combination of antibiotics. Each new composite part
can now be used iteratively in additional 2ab reactions to create progressively more complex parts.
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from strains of E. coli that specifically methylate BglII
(part J72015) and BamHI (part J72015) restriction
sites, respectively [7,8]. The methylation state of each
plasmid, which is different in “lefty” and “right” parts,dictates differential patterns of restriction digestion. In
“lefties,” BglII restriction sites are methylated, and thus
protected from digestion, while in “righties,” BamHI
restriction sites are methylated and protected from
digestion.
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one pot. Following isolation from their corresponding
methylation strains, “lefties” and “righties” are combined
together and digested with an enzyme cocktail containing
BglII, BamHI and XhoI. Given the methylation state of
each, “lefty” is cut with BamHI and XhoI, while “righty” is
cut with BglII and XhoI. This results in the generation of
two linear fragments per plasmid. As illustrated in Figure 2,
AK is digested such that the A resistance marker is now on
the same fragment of DNA as the “lefty” or 50 part, while
the K resistance marker is on its own. Similarly, KC is
digested such that the C resistance marker is now on the
same fragment of DNA as the “righty” or 30 part, while the
K resistance marker is on its own. Following digestion, a
ligation reaction recombines all the fragments to generate
four distinct possible plasmid architectures. Two are the
same as the parent plasmids, while the other two are
recombined child products.
Child plasmids are generated when BamHI overhangs
of the “lefty” vector and BglII overhangs of the “righty”
vector are ligated together on one end, and the two XhoI
overhangs are ligated together on the other end. The
desired child product contains a new composite part and
a new distinct permutation of antibiotic markers (AC in
this example), while the child byproduct contains no
part and two copies of the remaining antibiotic marker
(KK in this example). Given that each possible plasmid
architecture contains a different antibiotic combination,
desired child products can be selected away from
undesired products, as well as from parents, simply by
growing them in the appropriate antibiotic combination.
Each new composite part can now be used iteratively in
additional 2ab reactions to create progressively more
complex parts because all the elements necessary for
2ab assembly have been maintained: the new part is still
flanked by BglII and BamHI sites on its 50 and 30 ends,
respectively; and two antibiotic resistance genes are still
present and separated by an XhoI site. In order for the
next cycle of 2ab assembly to begin, new composite parts
need to be specified as lefties or righties (and methylated
accordingly), and compatible assembly vector partners
selected. In practice, these choices have been determined
by the assembly tree generated using AssemblyManager at
the outset of the assembly.
Screening of 2ab assembly
To measure the robustness of 2ab assembly, every junction
was assembled twice, in separate replicate experiments. For
every junction made, at least three independent colonies
containing putative composite parts were screened. All
colonies were subjected to several screens: the first was
growth phenotyping under various antibiotic combina-
tions; the second was restriction mapping or colony PCR
amplification; and the last was sequencing. These testswere performed in combination in order to ensure proper
part assembly at every stage.
In the first screen, single colonies were streaked onto
both double (AC, CK or KA, depending on the antibiotic
combination marking the new 2ab junction generated)
and triple (ACK) antibiotic combinations. Transformants
containing correctly assembled parts were able to grow on
the appropriate double antibiotic combination (indicating
they contained growth markers associated with correctly
assembled parts), but were not able to grow on the
triple antibiotic combination (indicating possible co-
transformation of one of the parent plasmids and/or
inappropriate assembly). As shown in Table 1, the aver-
age co-transformation rate was about 5% (111 of 2208),
indicating that the vast majority of transformants (2097
of 2208) contained growth markers associated with
properly assembled parts. Co-transformation rates
ranged from 2% for junctions between AK pairs, to 26%
for junctions between KC pairs. We routinely observe a
wide range of co-transformation rates. The variability is
mostly linked to two factors: first, the identity of the
antibiotic pair (CK and KC pairs show higher rates of
co-transformation than AC, CA, AK and KA pairs when
equivalent amounts of plasmid DNA are used); and
second, the concentration of plasmid DNA used for
transformation (higher amounts of plasmid DNA give
rise to higher rates of co-transformation).
Transformants showing the correct growth phenotype
were further screened either by restriction mapping with
BglII, BamHI and XhoI, or by colony PCR amplification.
Even though colony PCR amplification is preferable as a
screening tool because it does not require extraction of
plasmid DNA, which is costly and time-consuming, the
sizes of many stage 1 and 2 products could not be
clearly resolved from those of their parents with this
technique, and thus, were restriction mapped. All products
of stages 1 and 2 (104 total) were screened by restriction
mapping, while all products of stage 3 (528 total) were
screened by colony PCR.
A few clones from every stage of assembly, including
those with correct, questionable and incorrect restriction
maps or amplicons, were selected for sequencing to
verify part identity. As shown in Table 1, about 96% of
all colonies screened contained correctly assembly parts.
The percentages of properly assembled junctions ranged
from 93% for CA and KC pairs, to 100% for AK and KA
pairs. The results obtained by sequencing verify that our
restriction enzyme mapping and colony PCR screens
were stringent enough to assess assembly success accur-
ately. Of the clones showing correct restriction maps or
PCR amplicons sequenced (103 total), 100% contained
properly assembled parts. Of the clones with question-
able maps or PCR amplicons sequenced (8 total), 50%
contained properly assembled parts, indicating that we
Table 1 Summary of BglBricks-based 2ab assembly results
Assembly stage 1 2 3 Totals
junction type CA AK KC CK KA CA
junctions made 28 14 14 24 24 528 632
colonies screened by growth phenotype 84 42 42 156 156 1728 2208
co-transformants 3 1 11 12 7 77 111
% co-transformation 3.57 2.38 26.19 7.69 4.49 4.46 5.03
colonies screened by mapping or PCR 28 14 14 48 48 622 774
colonies w/ correct map or PCR phenotype 26 13 13 47 48 535 682
colonies w/ questionable map or PCR phenotype 2 1 1 0 0 75 79
colonies w/ incorrect map or PCR phenotype 0 0 0 1 0 12 13
colonies sequenced 9 1 14 9 8 73 114
colonies w/ correct map or PCR sequenced 7 1 13 9 8 65 103
correct sequencing result 7 1 13 9 8 65 103
colonies w/ questionable map or PCR sequenced 2 1 1 n/a n/a 4 8
correct sequencing result 0 1 0 n/a n/a 3 4
colonies w/ incorrect map or PCR sequenced n/a n/a n/a 0 n/a 4 4
correct sequencing result n/a n/a n/a n/a n/a 0 0
% correct assembly 92.86 100 92.86 97.92 100 95.06 96.45*
*Average of % assembly rates for every junction at various assembly stages.
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as assessed by restriction enzyme mapping and colony
PCR. Of the clones with incorrect restriction maps or
PCR amplicons sequenced (4 total), none contained
properly assembled parts.
To further test the robustness of 2ab assembly, we
compared the success rate obtained by BglBricks-based
2ab assembly to that obtained using a different assembly
standard also in the context of 2ab assembly. For this,
we chose the original BBF RFC10 standard described by
Knight [14], which uses SpeI and XbaI restriction sites
flanking the 50 and 30 ends of parts, respectively. Specific-
ally, we carried out a small assembly using a split version of
super folder-GFP [15], expressed under a constitutive pro-
moter, that results in visibly green colonies in E. coli when
properly assembled. The lefty input part consisted of the
first 173 amino acids of sf-GFP driven by the tet promoter,
while the righty input part consisted of the last 64 amino
acids of sf-GFP. Input parts were subcloned into all six 2ab
assembly vectors to test assembly of all junctions. Following
assembly, lefty and righty input parts are separated by a
small scar sequence (ACTAGA) encoding Thr-Arg, which
does not interfere with the fluorophore. As shown in
Table 2, the average co-transformation rate was about 14%
(174 of 1199), indicating that the vast majority of transfor-
mants (1025 of 1199) contained growth markers associated
with properly assembled parts. Co-transformation rates
ranged from 12% for junctions between KA pairs, to 19%
for junctions between CK pairs. Proper assembly was
further assessed by counting green colonies. About 92% ofcolonies screened (3221 of 3486) were positive for GFP
expression. The percentages of properly assembled junc-
tions ranged from 91% for CK pairs, to 95% for AC pairs.
To ensure that we were not under-reporting the number of
correct assemblies, we sequenced the assembly products
extracted from 26 white colonies. Of these, none contained
properly assembled parts, indicating that our screens were
robust enough to assess assembly success accurately.
Characterization of errors
In the process of assessing the robustness of our 2ab
assembly methodology we identified three main sources of
error. The first was co-transformation of plasmids, which
has been briefly mentioned above. Co-transformation
results in colonies that are able to grow in 2ab combina-
tions marking the newly assembled junction, but that may
or may not contain properly assembled parts. Instead,
these colonies contain antibiotic resistance markers
associated with correctly assembled junctions in one or
more plasmids that may or may not include the assembled
plasmid of interest. Although there was a slight qualitative
correlation between co-transformation and certain anti-
biotic combinations (CK and KC pairs showed higher
rates of co-transformation than AC, CA, AK and KA pairs
when equivalent amounts of plasmid DNA are used) there
was no correlation to part size or part source. Instead,
co-transformation was directly linked to the concentration
of plasmid DNA used in transformation reactions.
Higher amounts of plasmid DNA give rise to higher
rates of co-transformation, thus, a simple way to reduce
Table 2 Summary of BBF RFC10-based 2ab assembly results
Assembly stage 1 Totals
junction type CA AK KC CK KA AC
total junctions made 1 1 1 1 1 1 6
colonies screened by growth phenotype 200 198 201 200 199 201 1199
co-transformants 29 26 27 37 24 31 174
% co-transformation 14.50 13.13 13.43 18.5 12.06 15.42 14.51
total colonies counted 580 1011 274 366 688 567 3486
white colonies 45 83 24 34 48 31 265
green colonies 535 928 250 332 640 536 3221
total colonies sequenced 5 6 5 2 7 1 26
white colonies sequenced 5 6 5 2 7 1 26
correct sequencing result 0 0 0 0 0 0 0
green colonies sequenced 0 0 0 0 0 0 0
correct sequencing result n/a n/a n/a n/a n/a n/a 0
% correct assembly 92.24 91.79 91.24 90.71 93.02 94.53 92.40
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ation. Although co-transformation rates were not high
enough to present a problem in our assemblies, these
colonies can be easily screened and eliminated by simul-
taneously re-streaking on double and triple antibiotic
combinations. Colonies containing properly assembled
parts will be able to grow on two antibiotics marking the
newly assembled junction, but they will not be able to
grow on all three. Any colony that grows on triple antibiotic
combinations should be discarded.
A second, less common source of error (12 instances
out of 774), results in colonies that exhibit the appropri-
ate biotope, but that contain unrecognizable plasmids.
In every one of these cases, the failure could be corre-
lated back to poor quality parent input plasmid DNA
and corrected by re-extracting the input plasmid.
The last source of error resulted in the production of
junctions lacking whole input parts. In total, we identified
80 instances of BglBricks-based 2ab assembled junctions,
and 9 instances of BBF RFC10-based 2ab assembled
junctions, containing assembly scars but lacking either the
entire lefty or righty input part. In the case of BglBricks-
based assembly, empty junctions arise as a result of
incomplete methylation of parent plasmid DNA. When
input plasmids are incompletely methylated they are sub-
ject to part loss during digestion steps with BglII and
BamHI, which effectively eliminates the input part from
the reaction but maintains the vector backbone available
for 2ab assembly. In the case of BBF RFC10-based assem-
bly, empty junctions arise as a result of incomplete heat-
inactivation of restriction enzymes following digestion
steps, which has the same effect as incomplete methylation
of parent input DNA. Given that partial methylation is alimitation of the methylation strains themselves (which
have the potential to be significantly improved), rather than
of 2ab assembly per se, our reported success rate of 96% is
a conservative estimate of the actual rate, indicating that
our technology is indeed robust enough to construct large
error-free DNA sets with a very high success rate.
Screening the functionality of assembled bi-cistronic
operons
Addressing the bottleneck around DNA fabrication is
only the first step towards developing high-throughput
solutions in synthetic biology. Thus, in addition to showing
that our DNA assembly methodology is sufficiently robust
to build large error-free DNAs with a ~96% success rate,
we were interested in testing the functionality of assembled
constructs. To do this in a cellular context, we induced
expression and used indirect ELISA assays to quantify
steady-state relative protein expression levels from every
epitope-tagged Mediator subunit in all 528 bi-cistronic
operons (entire data set is provided in Additional files 3
and 4). For a select subset of operons, we also used sand-
wich ELISA assays to probe protein-protein interactions
and verify functionality of individually expressed proteins
(data not shown). For the purposes of this assembly
however, it was much more important to have a complete
data set that would allow us to comparatively asses operon
functionality (quantified by measuring relative protein ex-
pression levels via indirect ELISAs), than to asses individual
subunit functionality (quantified by measuring protein-
protein interactions via sandwich ELISAs). Given these pri-
orities, and given the large number of operons in the as-
sembly set (528 plasmids, assayed for two tags each, in
triplicate), we used indirect ELISAs, which are simpler and
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allowed us to make side-by-side comparisons and
predictions.
To assay the operons, they were first sorted by tag and
grouped together such that those with tags in common
were assayed in tandem in replicate experiments.
Figure 3 shows indirect ELISA data for a representative
set of constructs sharing VSV and E tags. Given that
each operon contains two different tags, and given 4
possible tagging architectures (NN, NC, CN and CC),
every pair of tags appears in 8 different constructs. In
the first four constructs VSV-Tag is fused to the first ORF
(Med7) and E-Tag to the second ORF (Med21). In the last
four constructs, which are “reciprocal” architectures, VSV-
Tag is fused to the second ORF (Med21) and E-Tag to the
first (Med7). The results show that varying the location of
the tag from the N- to the C-terminus of an ORF can have
a dramatic effect on protein expression levels. In this set,
Med7 expressed well when tagged at the C-terminus, but
significantly less so when tagged at the N-terminus. In turn,
Med 21 expressed at lower levels than Med7, either when
tagged at the N- or C-terminus.
High-throughput approaches such as these enable
rapid processing of large numbers of samples in parallel,
which in turn allows the simultaneous visualization of
multiple sets of data such that patterns can become
readily apparent. From these patterns, many of the ways
in which multiple variables influence experimental
outcomes begin to emerge. To test the hypothesis that
varying the location of the tags would have a more
significant effect on protein expression levels than
varying the identity of the tag itself, we plotted protein
concentration values obtained via ELISAs into “heat maps”
that included all possible tags and tagging combinations
(Additional file 3). In the context of a heat map, the
pattern of expression for Med7 becomes particularly
obvious. Regardless of which tag was used, Med7 expres-
sion levels were significantly higher when the protein was
tagged C-terminally. In some instances, Med7 expression
levels in excess of 55 fold over background were observed.
An exception to this pattern was FLAG, which resulted in
expression levels close to background in all architectures
tested. The pattern of expression for Med21 was a bit less
obvious than that for Med 7 because overall Med21
expressed at lower levels. In cases where patterns were
discernible, as in the case of tag combinations between
Avi, HSV and T7, for example, it was apparent that
Med21 expression tends to be higher when the protein is
tagged C-terminally.
Given the observed patterns we hypothesized that the
location of an ORF with respect to the driving promoter
would also influence expression, and specifically, that
expression from ORFs located proximally to the promoter
would be higher than from ORFs located distally. To testthis we assembled a small sub-set of 24 bi-cistronic
operons where we switched the location of the two ORFs,
placing Med21 in the first position, and Med7 in the
second. We selected three tags (Avi, HSV and T7) that
had shown discernible patterns in the first assembly and
tested them as before. Figure 4 shows that, while the tag
location patterns remained the same (both ORFs
expressed better when tagged C- rather N-terminally),
switching the location of the ORFs equalized protein
expression significantly. In the first assembly, where Med
7 was in the first ORF position and Med21 in the second
ORF position, the fold difference between the two highest
expressing architectures in the sub-set (Med7 at 44.82 and
Med21 at 12.06) was ~33 fold. In the second assembly,
where Med 21 was in the first position and Med7 the
second, the fold difference between the two highest
expressing architectures in the sub-set (Med21 at 9.48 and
Med7 at 8.35) decreased to ~1fold. Control of this variable
alone can have a significant impact on experimental
outcomes, which is particularly noteworthy given that
producing protein in stoichiometric equivalences that
enable formation of functional soluble complexes is often
more important than producing large quantities of non-
functional single subunits. Taken together, our results
confirm that recombinant protein expression is influenced
by multiple distinct variables that correlate with specific
sequences of DNA at specific locations in a plasmid. By
enabling the rapid and effective construction of plasmid
variants, 2ab assembly enables access and further control
over various experimental conditions which, in turn,
facilitate tuning of gene expression circuits used in
synthetic biology.
Discussion
We share the vision of synthetic biology as a field dedicated
to solving the technical and conceptual bottlenecks of
genetic engineering. Although we currently face several
challenges, it is clear that many of these obstacles can be
attributed either to an insufficient survey of the design
space or to a lack of knowledge about the molecular and
cellular functions of added components. Both of these
problems can be addressed by robust, cost-effective, rapid,
and outsourced DNA fabrication platforms that lower
barriers to fabrication and streamline assembly. Basic
standard biological parts, such as BioBricks™, as well as
standard assembly strategies to join them together head-to-
tail, have emerged as a way to deal with the potential
cloning problems associated with the uniqueness of each
DNA sequence. The rationale behind these approaches is
that by standardizing parts and part junctions to conform
to a particular set of rules, considerations of design and
function can be separated away from those pertaining to
assembly. Furthermore, because the products generated via
these methods are themselves standardized parts, a single,
Figure 3 Quantification of protein expression from differentially tagged ORFs. (A) Sample set-up for indirect and sandwich ELISA assays
used to quantify protein expression of individual subunits and protein-protein interactions, respectively. (B) Indirect ELISA data for a representative
set of 8 constructs sharing VSV and E tags. For any two tags, 8 different architectures are possible. In the first four constructs VSV-Tag (in blue) is
fused to the first ORF (Med7) and E-Tag (in red) to the second ORF (Med21). In the next four constructs, which are “reciprocal” architectures, VSV-
Tag is fused to the second ORF (Med21) and E-Tag to the first (Med7). Constructs with tags in common are assayed in tandem, replicate
experiments. Reported values are normalized for protein concentration and background. Control experiments include antibody drop-outs (not
shown) and protein extracts lacking epitope tags. (C) ELISA values plotted into “heat maps” to better visualize patterns of expression. The top two
maps show averaged values from replicate experiments, while the bottom two maps show the corresponding standard deviations. Maps on the
left show Med7 expression patterns from the first ORF position (on the “y” axis) and should be read from left to right. Maps on the right show
Med21expression patterns from the second ORF position (on the “x” axis) and should be read from top to bottom. Red and yellow colors indicate
high and low relative expression levels, respectively.
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Figure 4 Heat maps illustrating the effect of switching the location of specific ORFs relative to the driving promoter. Maps include all
possible tagging combinations for 24 bi-cistronic operons sharing tags Avi, HSV and T7. The top two maps illustrate patterns of expression for a
set of constructs where Med7 and Med 21 are located in the first and second ORF positions, respectively. The bottom two maps illustrates
patterns of expression for the same set of epitope tags only that Med7 and Med 21 are now located in the second and first ORF positions,
respectively. Maps on the left quantify expression levels for the first ORF (in the “y” axis) and should be read from left to right, whereas maps on
the right quantify expression levels from the second ORF (in the “x” axis) and should be read from top to bottom. As before, red and yellow
colors indicate high and low relative expression levels, respectively.
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enate parts together to form progressively more complex
genetic devices. Thus, the problem of composition can be
pursued without consideration for how the DNAs are
assembled together. Our results indicate that it is possible
to robustly and effectively automate the fabrication of
hundreds of genes using BioBricks™-based approaches.
Several alternate chemistries that can also be used as stand-
ard fabrication methods, including SOEing, SLIC, CPEC,
Golden Gate Shuffling, and the isothermal method reported
by Gibson [16-21], to name a few, have been recently devel-
oped. We anticipate that many of these could be similarly
automated, and thus, that specific types of experiments will
be better served by different assembly methodologies.
Although we currently lack specific benchmarks to
compare our results to those obtained using the alter-
nate chemistries mentioned above, a success rate above
96% for BioBricks™-based approaches is very encour-
aging, particularly since this is a conservative estimate of
efficiency that could be improved upon through minor
modifications of the existing set-up. The majority of
failures observed were related to colonies containingunrecognizable plasmids, which were always traced back
to poor quality input mini-prep DNA. Thus, these errors
could likely be mitigated using DNA extraction proto-
cols that perform more consistently. A second source of
failure was traced back to incomplete methylation of
input plasmid DNA, which gave rise to junctions lacking
either lefty or righty parts. These errors can be improved
upon with better methylation strains. Several of these
strains are currently under development in the lab. In a
few instances we also observed that particular combinations
of antibiotics performed better than others, which could
likely be resolved using DIAL strains or through modifica-
tions to regulatory elements, including promoter and/or
RBS mutations.
Automated assembly enables cumulative information
gain in every design cycle by lowering existing barriers
to construction and screening. Large numbers of data
points reveal patterns that reflect specific underlying
properties of the elements contained in a system.
Patterns can reflect several distinct variables. In the
examples presented here, two of the variables observed
to have a significant effect on relative protein expression
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and the location of that ORF relative to its driving pro-
moter (first or second position in a bi-cistronic operon).
As demonstrated previously, other variables can also be
used to manipulate expression systems, including RBS
and/or promoter mutations [22]. Further, these variables
can be used to test whether an engineered device is be-
having in a manner that is quantitatively consistent with
a particular model. Despite the fact that observed pat-
terns can be useful tools for the interpretation of results,
particularly because they enable informed decisions
about how the system should be manipulated in subse-
quent cycles, these trends can rarely be reliably mapped
onto specific biophysical parameters. Thus, one of the
main challenges we still face is how to encapsulate the
root of observed patterns. Ideally, combinatorial sets
could be used to quantify parameters that reflect inher-
ent properties of a particular part. As shown with the
test sets described here, the patterns observed had, at
the very least, qualitative utility for deciding whether ex-
pression levels of independent ORFs should be increased
or decreased, and by how much, in order to obtain stoi-
chiometric equivalences. Although it is tempting to try
to directly encapsulate measurements like ELISA or
fluorescence reads as relative measures of particular bio-
physical values, like transcription, translation or folding
rates, we want to root our theory of encapsulation in
real numbers that can be directly mapped to actual bio-
physical parameters reflecting molecular function, such as
a molecule’s Km, Kcat, folding rate, etc. Ironically perhaps,
the most central parameter that we currently manipulate
in synthetic biology, expression level, cannot be easily
characterized or encapsulated in terms of such para-
meters. To get there, one would be fully justified to ex-
press a sigma70 binding constant for a promoter, for
example. Nevertheless, that alone would not encapsulate
everything the promoter could do. In practice, transcrip-
tion rates would depend on many factors simultaneously
exerting an effect within the context of the cell, including
load and stress, to name just a few. Although reading
trends and patterns within a well-defined context is clearly
useful, we still have a long way to go before we can encap-
sulate information that seeks to define narrow parameters,
like whether a protein prefers to be tagged at the N- or C-
terminus, or whether using a particular tag will work on a
particular percentage of proteins or times. Given that
undoubtedly these are statements about molecular func-
tion that are related to folding kinetics, it will be neces-
sary to develop theory that will eventually enable us to
properly measure these types of parameters, such that
they can be reported in biophysically-justifiable terms.
Here we have successfully automated fabrication and
characterization of a large set of DNAs based on standard
biological parts. Although the process was neither easynor straightforward, it is clear that it was doable. In fact,
the theory of how to do this is simple, and implementation
difficulties stem from the fact that it is challenging to
automate this type of fabrication and characterization in a
single, streamlined liquid handling platform, not from any
intrinsic complications associated with the building of
large sets of DNAs on automated platforms. To do this
well in practice, it would need to be implemented in the
context of a centralized DNA fabrication facility that has
an assembly line of robots dedicated to specific tasks along
the assembly process. Given advances in acoustic liquid
handling and microfluidics, more streamlined hardware
solutions may soon be available. In the mean time, we
should state that the most striking observation coming
out of these studies was the lack of appropriate software
solutions available to integrate automation tools in a trad-
itional academic laboratory. Electronic information held in
our lab, like in many labs, is stored within an aggregation
of tools that provide reasonable organization for small
teams of researchers. These include sequence-management
programs like ApE, Google docs for tables of sequences,
parts, and samples, and wikis for experimental data.
Though tools such as the Registry of Standard Biological
Parts and ICE platforms provide excellent solutions for the
dissemination of sequence and qualitative usage informa-
tion, they do not support the full range of data types that
must be considered, tracked, and persisted for managing a
synthetic biology experiment. For large sets like ours, the
data entry process alone becomes unrealistically burden-
some when using only these tools, and the lack of cross-
tool communication leads to an enormous amount of
custom script writing simply to port information from
existing tools into the software needed to run the auto-
mation hardware. Further, it was clear that user errors,
custom notes, and non-standardized formats to freeform
documents make conversion into a standardized form
difficult and cumbersome. Despite rapid progress in the
area of BioCAD tools [6,23-27], basic day-to-day usability
and integration into wet-lab workflows remains one of the
outstanding challenges to fully realizing the benefits of
these tools.
BioCAD-driven wetlab automation has been identified
in both academia and industry as the primary driver of
new advances in genetic engineering. Considering the
biosafety and biosecurity risks associated with DNA
fabrication at this level of sophistication, it is important
that we begin to draft road maps of the major events in
the development of fabrication standards so that proper
practices can be anticipated and interventions imple-
mented a priori. This is particularly important given the
high level of interest that such technologies generate in
the DIY community. The question of whether individuals,
either acting alone or in small groups, could make use
of these advances to set-up clandestine operations is
Leguia et al. Journal of Biological Engineering 2013, 7:2 Page 13 of 16
http://www.jbioleng.org/content/7/1/2legitimate. In the absence of guarantees the answer
seems to be that although not easy at all, it would be
possible for teams of 2–3 people to generate a few hundred
DNA constructs a month using a similar, minimal automa-
tion setup. Clearly, DNA fabrication is just the first hurdle
to overcome in a series of required steps before a functional
microbial chemical factory is possible. Thus, although initial
barriers to entry may not be as high as desirable, increasing
the levels of throughput required for success bring about a
series of complications that are not easily overcome unless
one gets to a much larger operational scale, such as those
found in the context of successful and well-capitalized
biotech companies. When acting alone, members of the
DIY community could potentially work on applications
using BioCAD-driven design processes. However, efforts to
optimize processes using combinatorial approaches will
likely require external support from an angel investor or
well-capitalized fund in order to have a meaningful effect.
As we demonstrate with our particular data set, full
integration of automated tools into a wet-lab environment
will require not only hardware, bioware, and software, but
also a complete set of tools that are responsive to the
practical needs and practices of wet-lab researchers and
can manage the information already held in synthetic
biology labs. Fortunately, there is great interest within the
synthetic biology community to develop community-shared
data standards and interoperating procedures [28] that
should significantly facilitate progress in moving forward in
an ethical and safe manner.Conclusions
We have shown the use of an integrated tool chain from
abstract design through to fabrication and analysis. The
composite devices assembled in our set contained a total
of 3696 junctions between parts (out of which 632 are
unique) and were assembled in three steps in about
1 month at a cost (without labor) around $4000. From
this we have learned that, as it currently stands, the
methodology is robust enough to construct hundreds of
large error-free DNAs with a 96% success rate. Though
there remain many challenges to fully incorporating
these automation workflows into the wet-lab work flow,
it is clear that this is doable and provides rich information
to accelerate the process of engineering specific devices
and a critical tool for the development of a robust
encapsulation theory.Methods
Materials
Unless otherwise specified, all enzymes were purchased
from NEB (Ipswich, MA). Oligos were purchased from
IDT (San Diego, CA) and used unpurified. Antibodies
were purchased from GenScript (Piscataway, NJ), Bethyl(Montgomery, TX) and Abcam (Cambridge, MA) and
used at the dilutions specified below.
Construction of basic parts
The Registry of Standard Biological Parts (http://
partsregistry.org), which is searchable by part number,
provides details on the construction of all basic parts used
in this study. Additional file 1 lists both part number for
the Registry, and ID number for the non-profit plasmid
repository Addgene (www.addgene.org). Sequences for the
oligos needed to gene synthesize basic parts were generated
using OligoDesigner (http://andersonlab.qb3.berkeley.edu/
andersonSoftware.html). All parts were codon optimized
for expression in E. coli. Undesirable restriction enzyme
sites (BamHI, BglII, EcoRI and XhoI) were removed using
GeneDesign (http://baderlab.bme.jhu.edu/gd/). Part identity
was confirmed by sequencing, which was outsourced to
Quintara (Berkeley, CA). For maintenance, parts were
digested with EcoRI and BamHI, and directionally cloned
into various 2ab assembly vectors prior to transformation
into MC1061 or derivatives [7,8]. All part and vector
sequences, as well as physical DNAs and relevant bacterial
strains, are available through Addgene.
2ab assembly of composite parts
All junctions between parts were generated by 2ab as-
sembly using a minimal hardware platform consisting of
a liquid handling robot (Beckman Coulter Biomek 3000
Laboratory Automation Workstation), a plate-spinning
bench-top centrifuge (Beckman Coulter Allegra™ 25R)
and a 96-well plate thermocycler (MJ Research PTC-200
Peltier Thermal Cycler), with additional support from a
software tool called AssemblyManager. Detailed methods
for the implementation of 2ab assembly on the Biomek
3000 liquid handling robot have been previously described
[7], and sample robot files required to carry out these
protocols, as well as the AssemblyManager software tool,
are available for download (http://andersonlab.qb3.berkeley.
edu/andersonSoftware.html). Briefly, 2ab assembly proceeds
in iterative cycles of 3 steps per cycle: in the first step
plasmid DNA is digested with restriction enzymes to
generate lefty and righty fragments; in the second step
DNA fragments are ligated back together to generate
new plasmid combinations; and in the last step plasmids
are transformation into E. coli for selection and screening.
For BglBricks-based 2ab assembly, digestion reactions
were carried out in one-pot at 37°C for 1 hr, in 96-well
PCR plates, in 16 μL volumes containing 10 μL of digestion
cocktail (1 μL 10X NEB Buffer 2, 0.5 μL BamHI, 0.5 μL
BglII, 0.5 μL XhoI, 7.5 μL water) and 3 μL each lefty and
rightly input plasmids. Lefty and righty parts were gen-
erated by transforming and harvesting plasmids from
BglII- and BamHI-methylating strains (parts J72007
and J72013), respectively [7,8]. These strains are pir +
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all assembly vectors. Following digestion, restriction
enzymes were heat-killed at 65°C for 20 min. Ligation
reactions were carried out at room temperature for
30 min by adding 4 μL of ligation cocktail (0.4 μL NEB
Buffer 2, 2 μL 10 mM ATP, 0.5 μL T4 DNA ligase, 1.1 μL
water) into each heat-killed 16 μL digestion reaction.
Transformation reactions were carried out by adding
30 μL of chemically competent cells, made using either
the BglII- or the BamHI-methylating strain, into each
20 μL ligation. Following incubation on ice for 10 min,
cells were heat shocked at 42°C for 3 min, and then
rescued by adding 100 μL of 2YT and incubating at 37°C
for 30 min. Transformations were then plated onto LB
agar strips supplemented with appropriate antibiotic
combinations (ampicillin at 100 ug/mL, chloramphenicol
at 25 ug/mL and kanamycin at 25 ug/mL) using 24-well
strip plates (Analytical Sales & Services, cat# 47025). BBF
RFC10-based 2ab assembly was carried out similarly to
BglBricks-based 2ab assembly, but with minor modifica-
tions due to a lack of strains capable of methylating SpeI
or XbaI sites. Lefty and righty plasmids were digested
separately, at 37°C for 1 hr, in 8 μL volumes containing
5 μL of SpeI and XhoI or XbaI and XhoI digestion cocktail
(0.5 μL 10X NEB Buffer 2, 0.25 μL each enzyme, 4 μL
water) and 3 μL each lefty or rightly input plasmids. Fol-
lowing digestion, restriction enzymes were heat-killed at
80°C for 20 min. Righty and lefty products were then com-
bined in one pot prior to ligation and transformation,
which were carried out exactly as described above.
Screening of assembled composite parts
Transformants containing putative composite parts were
subjected to various screens at every stage of assembly:
the first screen was growth under various antibiotic
combinations; the second was restriction enzyme
mapping or colony PCR amplification; and the last was
sequencing. For growth screens, single colonies were
spotted onto LB agar plates containing both double (AC,
CK or KA) and triple (ACK) antibiotic combinations and
grown overnight at 37°C prior to scoring. Transformants
with the correct growth phenotype were then screened ei-
ther by restriction enzyme mapping or by colony PCR. For
restriction enzyme mapping, plasmid DNA was extracted
using NucleoSpin plasmid columns (Machery-Nagel), either
in single or Multi-8 format, according to the manufacturer’s
directions, and digested with BglII, BamHI and XhoI diges-
tion cocktail as above. For colony PCR amplification, single
colonies were grown overnight at 37°C in 96 well blocks
(Analytical Sales & Services, cat# 27P687) containing 1 mL
LB liquid medium supplemented with appropriate antibio-
tics. PCR assays were carried out in 20 μL volumes using
96-well PCR plates. The reaction mixture contained 0.5
units of Taq DNA polymerase, 1.5 mM MgCl, 200 uMdNTPs, 200uM each oligo (ca998: GTATCACGAGGCA
GAATTTCAG and G00101: ATTACCGCCTTTGAGT
GAGC) and approximately 0.13 μL of saturated bacterial
culture, transferred into the 96-well plate containing the
reaction mixture using a 96-pin tool (V&P Scientific,
cat#246A). Sequencing was outsourced to Quintara
(Berkeley, CA).
Cell lysates
Prior to ELISAs, cell lysates were prepared from induced
E. coli strain pir-116 containing the composite part of
interest. Briefly, frozen glycerol stocks were used to
inoculate 1 mL 2YT liquid medium supplemented with
antibiotics and grown overnight at 37°C in 96 well blocks.
The next morning, saturated cultures were diluted 1:500
into fresh 1 mL aliquots of 2YT liquid medium, supple-
mented with antibiotics and 0.2% arabinose. These were
grown overnight again at 37°C in 96 well blocks. Induced
cultures were then pelleted by centrifugation for 5 min at
5400 g and resuspended in 100 μL of Bugbuster HT
(Novagen) by vortexing. After a 20–30 min incubation
period at room temperature, lysates were cleared by cen-
trifugation for 5 min at 5400 g, and protein concentration
determined by BCA assay (Pierce) according to the
manufacturer’s directions. Absorbance was measured at
562 nm using a Tecan Safire 2 plate reader. Lysates were
diluted 1:10 in TBST (50 mM Tris pH 7.8, 150 mM NaCl,
0.05% Tween-20) prior to use.
ELISAs
All ELISA assays were carried out using commercially
available affinity purified antibodies (Additional file 2).
Indirect ELISAs were used to quantify protein expression,
whereas sandwhich ELISAs were used to quantify protein-
protein interactions. For indirect ELISAs, 40 μL of cleared
cell lysate were absorbed onto a 96-well ELISA plate
(NUNC) at room temperature for 1 hr. Following absorp-
tion, wells were washed 3X with 200 μL TBST at room
temperature for 10 min. Wells were then blocked using
200 μL of StartingBlock™ Buffer (Thermo Scientific) accor-
ding to the manufacturer’s directions. Following blocking,
wells were washed 3X as described and 100 μL of TBST
containing primary antibodies against one of twelve epitope
tags (diluted 1:3000) were applied at room temperature for
1 hr. Wells were washed 3X and 100 μL of TBST contain-
ing HRP-conjugated secondary antibodies against the con-
stant region of the detecting primary antibody (diluted
1:5000) were applied at room temperature for 1 hr. Wells
were washed 3X and 100 μL of 1-Step Ultra TMB-ELISA
reagent (Thermo Scientific) were applied, followed by
100 μL of 2 M sulfuric acid to stop the reaction. Absorb-
ance was measured at 450 nm using a Tecan Safire 2 plate
reader. For sandwich ELISAs, 100 μL of carbonate buffer
containing antibodies against one of twelve epitope tags
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4°C overnight. Following absorption, wells were washed 3X
with 200 μL TBST at room temperature for 10 min and
then blocked using 200 μL of StartingBlock™ Buffer. Fol-
lowing blocking, wells were washed 3X and 40 μL of
cleared cell lysate applied at room temperature for 1 hr.
Wells were washed 3X and 100 μL of TBST containing
detecting primary antibodies against the second tag in the
complex (diluted 1:3000) were applied at room temperature
for 1 hr. The remaining washes, addition of the secondary
HRP-conjugated antibodies (diluted 1:5000), addition of the
TMB-ELISA reagent and of the sulfuric acid, as well as the
absorbance measurements, were carried out as described in
the indirect ELISA protocol. All ELISAs were performed in
triplicate. Values were normalized for protein concentration
and background. Control experiments included antibody
drop-outs and the use of protein extracts lacking the
epitope tags being assayed.
Additional files
Additional file 1: Basic parts used for BglBricks-based 2ab assembly
of bi-cistronic operons of Mediator complex.
Additional file 2: Antibodies used in ELISA assays.
Additional file 3: Heat maps of protein concentration values
obtained via indirect ELISAs. Maps include all possible tags and
tagging combinations in order to visualize expression patterns for each
epitope-tagged ORF in all 528 bi-cistronic operons. The top map
illustrates patterns of expression for Med7 located in the first ORF
position and should be read from left to right. The bottom map
illustrates patterns of expression for Med21 located in the second ORF
position and should be read from top to bottom. Red color indicates
high relative expression, whereas yellow color indicates low relative
expression.The complete data set, including standard deviation values,
are provided in Additional file 4.
Additional file 4: Complete data set of protein concentration values
obtained via indirect ELISAs from all 528 bi-cistronic operons.
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